Inogen | Despesas Operacionais





Despesas Operacionais Alterar Data
Abbott USD 9.21B 17M 2025-12
AngioDynamics USD 81.98M 1.96M 2025-02
AtriCure USD 134.06M 8.27M 2025-09
Baxter International USD 2.63B 95.8M 2025-09
Becton, Dickinson and Co. USD 4.59B 476M 2025-12
Boston Scientific USD 4.04B 18M 2025-12
Chart Industries USD 923.1M 10.3M 2025-09
Cooper Companies USD 924.8M 40.2M 2025-09
Dexcom USD 966.8M 22.3M 2025-09
Edwards Lifesciences USD 1.2B 71.3M 2025-12
Globus Medical USD 886.57M 730.06M 2025-09
Inogen USD 49.14M 665K 2024-09
Insulet USD 588.6M 60.6M 2025-09
Masimo USD 147M 159.4M 2025-09
Medtronic USD 7.26B 283M 2025-09
Orthofix International USD 10.89M 209.57M 2024-09
Philips EUR 4.38B 405M 2025-12
ResMed USD 925.21M 51.98M 2025-12
Steris USD 1.22B 28.8M 2025-12
Stryker USD 5.2B 505M 2025-12
Tandem Diabetes Care USD 272.12M 421K 2025-09
Teleflex USD 3.82B 3.22B 2025-09
X T L Biopharmaceuticals USD 1.1M 175K 2024-12
Zimmer Biomet Holdings USD 1.94B 277.8M 2025-12


Inogen Despesas Operacionais - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Feb 2026.